 | • レポートコード：GIR-105X01081 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、降圧薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。降圧薬の種類別市場規模（利尿性降圧薬、交感神経抑制薬、レニン-アンギオテンシン系阻害薬、カルシウム拮抗薬、血管拡張薬）、用途別市場規模（高齢者、妊婦、一般患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・降圧薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Pfizer、Johnson & Johnson、Sanofi、Lupin、Ranbaxy Laboratories、Merck、Astra Zeneca、Daiichi Sankyo、Takeda、Actelion、United Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：利尿性降圧薬、交感神経抑制薬、レニン-アンギオテンシン系阻害薬、カルシウム拮抗薬、血管拡張薬 ・用途別分析2016年-2026年：高齢者、妊婦、一般患者 ・降圧薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・降圧薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・降圧薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・降圧薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・降圧薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antihypertensive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antihypertensive Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Antihypertensive Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Antihypertensive Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diuretic Antihypertensive
Sympathetic Suppressant
Renin-angiotensin System Inhibitor
Calcium Antagonist Medicine
vasodilator
Market segment by Application can be divided into
The Old
Pregnant Woman
General Patient
The key market players for global Antihypertensive Drugs market are listed below:
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Antihypertensive Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antihypertensive Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Diuretic Antihypertensive
1.2.3 Sympathetic Suppressant
1.2.4 Renin-angiotensin System Inhibitor
1.2.5 Calcium Antagonist Medicine
1.2.6 vasodilator
1.3 Market Analysis by Application
1.3.1 Overview: Global Antihypertensive Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 The Old
1.3.3 Pregnant Woman
1.3.4 General Patient
1.4 Global Antihypertensive Drugs Market Size & Forecast
1.4.1 Global Antihypertensive Drugs Sales in Value (2016-2026))
1.4.2 Global Antihypertensive Drugs Sales in Volume (2016-2026)
1.4.3 Global Antihypertensive Drugs Price by Type (2016-2026) & (USD/K Pcs)
1.5 Global Antihypertensive Drugs Production Capacity Analysis
1.5.1 Global Antihypertensive Drugs Total Production Capacity (2016-2026)
1.5.2 Global Antihypertensive Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antihypertensive Drugs Market Drivers
1.6.2 Antihypertensive Drugs Market Restraints
1.6.3 Antihypertensive Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Antihypertensive Drugs Product and Services
2.1.4 Novartis Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Antihypertensive Drugs Product and Services
2.2.4 Pfizer Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Antihypertensive Drugs Product and Services
2.3.4 Johnson & Johnson Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Antihypertensive Drugs Product and Services
2.4.4 Sanofi Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Lupin
2.5.1 Lupin Details
2.5.2 Lupin Major Business
2.5.3 Lupin Antihypertensive Drugs Product and Services
2.5.4 Lupin Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Ranbaxy Laboratories
2.6.1 Ranbaxy Laboratories Details
2.6.2 Ranbaxy Laboratories Major Business
2.6.3 Ranbaxy Laboratories Antihypertensive Drugs Product and Services
2.6.4 Ranbaxy Laboratories Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Antihypertensive Drugs Product and Services
2.7.4 Merck Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Astra Zeneca
2.8.1 Astra Zeneca Details
2.8.2 Astra Zeneca Major Business
2.8.3 Astra Zeneca Antihypertensive Drugs Product and Services
2.8.4 Astra Zeneca Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business
2.9.3 Daiichi Sankyo Antihypertensive Drugs Product and Services
2.9.4 Daiichi Sankyo Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Antihypertensive Drugs Product and Services
2.10.4 Takeda Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Actelion
2.11.1 Actelion Details
2.11.2 Actelion Major Business
2.11.3 Actelion Antihypertensive Drugs Product and Services
2.11.4 Actelion Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 United Therapeutics
2.12.1 United Therapeutics Details
2.12.2 United Therapeutics Major Business
2.12.3 United Therapeutics Antihypertensive Drugs Product and Services
2.12.4 United Therapeutics Antihypertensive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Antihypertensive Drugs Sales by Manufacturer
3.1 Global Antihypertensive Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Antihypertensive Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Antihypertensive Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Antihypertensive Drugs Manufacturer Market Share
3.4.2 Top 6 Antihypertensive Drugs Manufacturer Market Share
3.5 Global Antihypertensive Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Antihypertensive Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antihypertensive Drugs Market Size by Region
4.1.1 Global Antihypertensive Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Antihypertensive Drugs Revenue by Region (2016-2026)
4.2 North America Antihypertensive Drugs Revenue (2016-2026)
4.3 Europe Antihypertensive Drugs Revenue (2016-2026)
4.4 Asia-Pacific Antihypertensive Drugs Revenue (2016-2026)
4.5 South America Antihypertensive Drugs Revenue (2016-2026)
4.6 Middle East and Africa Antihypertensive Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Antihypertensive Drugs Sales in Volume by Type (2016-2026)
5.2 Global Antihypertensive Drugs Revenue by Type (2016-2026)
5.3 Global Antihypertensive Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Antihypertensive Drugs Sales in Volume by Application (2016-2026)
6.2 Global Antihypertensive Drugs Revenue by Application (2016-2026)
6.3 Global Antihypertensive Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Antihypertensive Drugs Sales by Type (2016-2026)
7.2 North America Antihypertensive Drugs Sales by Application (2016-2026)
7.3 North America Antihypertensive Drugs Market Size by Country
7.3.1 North America Antihypertensive Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Antihypertensive Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Antihypertensive Drugs Sales by Type (2016-2026)
8.2 Europe Antihypertensive Drugs Sales by Application (2016-2026)
8.3 Europe Antihypertensive Drugs Market Size by Country
8.3.1 Europe Antihypertensive Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Antihypertensive Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Antihypertensive Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Antihypertensive Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Antihypertensive Drugs Market Size by Region
9.3.1 Asia-Pacific Antihypertensive Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Antihypertensive Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Antihypertensive Drugs Sales by Type (2016-2026)
10.2 South America Antihypertensive Drugs Sales by Application (2016-2026)
10.3 South America Antihypertensive Drugs Market Size by Country
10.3.1 South America Antihypertensive Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Antihypertensive Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antihypertensive Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Antihypertensive Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Antihypertensive Drugs Market Size by Country
11.3.1 Middle East & Africa Antihypertensive Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Antihypertensive Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Antihypertensive Drugs Typical Distributors
12.3 Antihypertensive Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Antihypertensive Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Antihypertensive Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Antihypertensive Drugs Product and Services
Table 6. Novartis Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Antihypertensive Drugs Product and Services
Table 10. Pfizer Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Antihypertensive Drugs Product and Services
Table 14. Johnson & Johnson Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Antihypertensive Drugs Product and Services
Table 18. Sanofi Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Lupin Basic Information, Manufacturing Base and Competitors
Table 20. Lupin Major Business
Table 21. Lupin Antihypertensive Drugs Product and Services
Table 22. Lupin Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Ranbaxy Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Ranbaxy Laboratories Major Business
Table 25. Ranbaxy Laboratories Antihypertensive Drugs Product and Services
Table 26. Ranbaxy Laboratories Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Antihypertensive Drugs Product and Services
Table 30. Merck Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 32. Astra Zeneca Major Business
Table 33. Astra Zeneca Antihypertensive Drugs Product and Services
Table 34. Astra Zeneca Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 36. Daiichi Sankyo Major Business
Table 37. Daiichi Sankyo Antihypertensive Drugs Product and Services
Table 38. Daiichi Sankyo Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Takeda Basic Information, Manufacturing Base and Competitors
Table 40. Takeda Major Business
Table 41. Takeda Antihypertensive Drugs Product and Services
Table 42. Takeda Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Actelion Basic Information, Manufacturing Base and Competitors
Table 44. Actelion Major Business
Table 45. Actelion Antihypertensive Drugs Product and Services
Table 46. Actelion Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. United Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. United Therapeutics Major Business
Table 49. United Therapeutics Antihypertensive Drugs Product and Services
Table 50. United Therapeutics Antihypertensive Drugs Sales (M Pcs), Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Antihypertensive Drugs Sales by Manufacturer (2019-2021e) & (M Pcs)
Table 52. Global Antihypertensive Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Antihypertensive Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Antihypertensive Drugs Production Capacity by Company, (M Pcs): 2020 VS 2021
Table 55. Head Office and Antihypertensive Drugs Production Site of Key Manufacturer
Table 56. Global Antihypertensive Drugs Sales by Region (2016-2021e) & (M Pcs)
Table 57. Global Antihypertensive Drugs Sales by Region (2021-2026) & (M Pcs)
Table 58. Global Antihypertensive Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Antihypertensive Drugs Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Antihypertensive Drugs Sales by Type (2016-2021e) & (M Pcs)
Table 61. Global Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs)
Table 62. Global Antihypertensive Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Antihypertensive Drugs Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Antihypertensive Drugs Price by Type (2016-2021e) & (USD/K Pcs)
Table 65. Global Antihypertensive Drugs Price by Type (2021-2026) & (USD/K Pcs)
Table 66. Global Antihypertensive Drugs Sales by Application (2016-2021e) & (M Pcs)
Table 67. Global Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs)
Table 68. Global Antihypertensive Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Antihypertensive Drugs Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Antihypertensive Drugs Price by Application (2016-2021e) & (USD/K Pcs)
Table 71. Global Antihypertensive Drugs Price by Application (2021-2026) & (USD/K Pcs)
Table 72. North America Antihypertensive Drugs Sales by Country (2016-2021e) & (M Pcs)
Table 73. North America Antihypertensive Drugs Sales by Country (2021-2026) & (M Pcs)
Table 74. North America Antihypertensive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Antihypertensive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Antihypertensive Drugs Sales by Type (2016-2021e) & (M Pcs)
Table 77. North America Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs)
Table 78. North America Antihypertensive Drugs Sales by Application (2016-2021e) & (M Pcs)
Table 79. North America Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs)
Table 80. Europe Antihypertensive Drugs Sales by Country (2016-2021e) & (M Pcs)
Table 81. Europe Antihypertensive Drugs Sales by Country (2021-2026) & (M Pcs)
Table 82. Europe Antihypertensive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Antihypertensive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Antihypertensive Drugs Sales by Type (2016-2021e) & (M Pcs)
Table 85. Europe Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs)
Table 86. Europe Antihypertensive Drugs Sales by Application (2016-2021e) & (M Pcs)
Table 87. Europe Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs)
Table 88. Asia-Pacific Antihypertensive Drugs Sales by Region (2016-2021e) & (M Pcs)
Table 89. Asia-Pacific Antihypertensive Drugs Sales by Region (2021-2026) & (M Pcs)
Table 90. Asia-Pacific Antihypertensive Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Antihypertensive Drugs Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Antihypertensive Drugs Sales by Type (2016-2021e) & (M Pcs)
Table 93. Asia-Pacific Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs)
Table 94. Asia-Pacific Antihypertensive Drugs Sales by Application (2016-2021e) & (M Pcs)
Table 95. Asia-Pacific Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs)
Table 96. South America Antihypertensive Drugs Sales by Country (2016-2021e) & (M Pcs)
Table 97. South America Antihypertensive Drugs Sales by Country (2021-2026) & (M Pcs)
Table 98. South America Antihypertensive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Antihypertensive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Antihypertensive Drugs Sales by Type (2016-2021e) & (M Pcs)
Table 101. South America Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs)
Table 102. South America Antihypertensive Drugs Sales by Application (2016-2021e) & (M Pcs)
Table 103. South America Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs)
Table 104. Middle East & Africa Antihypertensive Drugs Sales by Country (2016-2021e) & (M Pcs)
Table 105. Middle East & Africa Antihypertensive Drugs Sales by Country (2021-2026) & (M Pcs)
Table 106. Middle East & Africa Antihypertensive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Antihypertensive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Antihypertensive Drugs Sales by Type (2016-2021e) & (M Pcs)
Table 109. Middle East & Africa Antihypertensive Drugs Sales by Type (2021-2026) & (M Pcs)
Table 110. Middle East & Africa Antihypertensive Drugs Sales by Application (2016-2021e) & (M Pcs)
Table 111. Middle East & Africa Antihypertensive Drugs Sales by Application (2021-2026) & (M Pcs)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Antihypertensive Drugs Typical Distributors
Table 115. Antihypertensive Drugs Typical Customers
List of Figures
Figure 1. Antihypertensive Drugs Picture
Figure 2. Global Antihypertensive Drugs Sales Market Share by Type in 2020
Figure 3. Diuretic Antihypertensive
Figure 4. Sympathetic Suppressant
Figure 5. Renin-angiotensin System Inhibitor
Figure 6. Calcium Antagonist Medicine
Figure 7. vasodilator
Figure 8. Global Antihypertensive Drugs Sales Market Share by Application in 2020
Figure 9. The Old
Figure 10. Pregnant Woman
Figure 11. General Patient
Figure 12. Global Antihypertensive Drugs Market Size, (USD Million) & (M Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Antihypertensive Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Antihypertensive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Antihypertensive Drugs Sales (2016-2026) & (M Pcs)
Figure 34. Global Antihypertensive Drugs Production Capacity (2016-2026) & (M Pcs)
Figure 35. Global Antihypertensive Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Antihypertensive Drugs Market Drivers
Figure 37. Antihypertensive Drugs Market Restraints
Figure 38. Antihypertensive Drugs Market Trends
Figure 39. Global Antihypertensive Drugs Sales Market Share by Manufacturer in 2020
Figure 40. Global Antihypertensive Drugs Revenue Market Share by Manufacturer in 2020
Figure 41. Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Antihypertensive Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Antihypertensive Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Antihypertensive Drugs Sales Market Share by Region (2016-2026)
Figure 45. Global Antihypertensive Drugs Revenue Market Share by Region (2016-2026)
Figure 46. North America Antihypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Europe Antihypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Antihypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 49. South America Antihypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Antihypertensive Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Global Antihypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 52. Global Antihypertensive Drugs Revenue Market Share by Type (2016-2026)
Figure 53. Global Antihypertensive Drugs Price by Type (2016-2026) & (USD/K Pcs)
Figure 54. Global Antihypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 55. Global Antihypertensive Drugs Revenue Market Share by Application (2016-2026)
Figure 56. Global Antihypertensive Drugs Price by Application (2016-2026) & (USD/K Pcs)
Figure 57. North America Antihypertensive Drugs Sales Market Share by Country (2016-2026)
Figure 58. North America Antihypertensive Drugs Revenue Market Share by Country (2016-2026)
Figure 59. North America Antihypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 60. North America Antihypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 61. Europe Antihypertensive Drugs Sales Market Share by Country (2016-2026)
Figure 62. Europe Antihypertensive Drugs Revenue Market Share by Country (2016-2026)
Figure 63. Europe Antihypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 64. Europe Antihypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Antihypertensive Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Antihypertensive Drugs Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Antihypertensive Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Antihypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Antihypertensive Drugs Sales Market Share by Country (2016-2026)
Figure 70. South America Antihypertensive Drugs Revenue Market Share by Country (2016-2026)
Figure 71. South America Antihypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 72. South America Antihypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Antihypertensive Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Antihypertensive Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Antihypertensive Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Antihypertensive Drugs Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
高血圧薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These def…- 心血管薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cardiovascular Drugs and Therapy is a bimonthly peer-reviewed medical journal covering pharmacotherapy as it relates to cardiology. It was established in 1987 and is published by Springer Science+Business Media on behalf of the International Society of Cardiovascular Pharmacotherapy, of which it is …
- 慢性腎疾患（CKD）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function. Scope of the Report: This report focuses on the Chronic Kidney Disease (CKD) Drugs in global market, especially in North America, Europe a…
- 制吐薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer. Scope of the Report: This report foc…
- 世界の腫瘍壊死因子（TNF）阻害薬市場 2021：企業別、地域別、種類・用途別 The Tumor Necrosis Factor (TNF) Inhibitor Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…